10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Blockade of Estrogen Action Upregulates Estrogen Receptor-α mRNA in the Fetal Brain

      research-article
      , *
      Neonatology
      S. Karger AG
      Sheep fetus, Hippocampus, Cerebellum, Faslodex, Fulvestrant

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Fetal neuroendocrine maturation in late gestation is critical for maintenance of fetal homeostasis, growth, and readiness for birth. Sheep express estrogen receptors (ERs) in various brain regions. However, little is known about the regulation of ER-α and ER-β in the ovine brain prenatally.

          Objective

          The present study was designed to test the hypothesis that the expression of ER is influenced by circulating estrogens in the late-gestation sheep fetus.

          Methods

          Six chronically-catheterized twin fetal sheep were treated with vehicle or the ER blocker ICI 182,780 i.c.v. (0.25 μg/day). Fetuses were sacrificed 6–14 days after surgery and start of infusion. Brain regions were rapidly isolated and snap-frozen for later extraction of mRNA and protein. ER-α and ER-β mRNA was measured using real-time PCR and protein was measured using Western blot.

          Results

          Treatment with ICI 182,780 increased ER-α mRNA, especially in cerebellum and hippocampus. There were no changes in ER-α protein and no changes in ER-β at either the mRNA or protein level.

          Conclusion

          Expression of ER-α is influenced by endogenous estrogens in the ovine fetal brain.

          Related collections

          Most cited references25

          • Record: found
          • Abstract: found
          • Article: not found

          Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action

          Due to their favourable tolerability profiles, endocrine therapies have long been considered the treatment of choice for hormone-sensitive metastatic breast cancer. However, the oestrogen agonist effects of the available selective oestrogen receptor modulators, such as tamoxifen, and the development of cross-resistance between endocrine therapies with similar modes of action have led to the need for new treatments that act through different mechanisms. Fulvestrant (‘Faslodex’) is the first of a new type of endocrine treatment – an oestrogen receptor (ER) antagonist that downregulates the ER and has no agonist effects. This article provides an overview of the current understanding of ER signalling and illustrates the unique mode of action of fulvestrant. Preclinical and clinical study data are presented in support of the novel mechanism of action of this new type of ER antagonist.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The circulation of the fetus in utero. Methods for studying distribution of blood flow, cardiac output and organ blood flow.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Differential regulation of estrogen-inducible proteolysis and transcription by the estrogen receptor alpha N terminus.

              The ubiquitin-proteasome pathway has emerged as an important regulatory mechanism governing the activity of several transcription factors. While estrogen receptor alpha (ERalpha) is also subjected to rapid ubiquitin-proteasome degradation, the relationship between proteolysis and transcriptional regulation is incompletely understood. Based on studies primarily focusing on the C-terminal ligand-binding and AF-2 transactivation domains, an assembly of an active transcriptional complex has been proposed to signal ERalpha proteolysis that is in turn necessary for its transcriptional activity. Here, we investigated the role of other regions of ERalpha and identified S118 within the N-terminal AF-1 transactivation domain as an additional element for regulating estrogen-induced ubiquitination and degradation of ERalpha. Significantly, different S118 mutants revealed that degradation and transcriptional activity of ERalpha are mechanistically separable functions of ERalpha. We find that proteolysis of ERalpha correlates with the ability of ERalpha mutants to recruit specific ubiquitin ligases regardless of the recruitment of other transcription-related factors to endogenous model target genes. Thus, our findings indicate that the AF-1 domain performs a previously unrecognized and important role in controlling ligand-induced receptor degradation which permits the uncoupling of estrogen-regulated ERalpha proteolysis and transcription.
                Bookmark

                Author and article information

                Journal
                Neonatology
                Neonatology
                NEO
                Neonatology
                S. Karger AG (Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH–4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.ch )
                1661-7800
                1661-7819
                August 2009
                12 March 2009
                1 August 2010
                : 96
                : 2
                : 115-119
                Affiliations
                Department of Physiology and Functional Genomics, University of Florida College of Medicine, Gainesville, Fla., USA
                Author notes
                *Charles E. Wood, PhD, Department of Physiology and Functional Genomics, University of Florida College of Medicine, PO Box 100274, Gainesville, FL 32610-0274 (USA), Tel. +1 352 392 4488, Fax +1 352 392 8340, E-Mail cwood@ 123456phys.med.ufl.edu
                Article
                neo-0096-0115
                10.1159/000208793
                2793321
                19279395
                40824db7-e579-4343-bb28-ce3c22e289a8
                Copyright © 2009 by S. Karger AG, Basel

                This is an open access article distributed under the terms of Karger's Author's Choice™ licensing agreement, adapted from the Creative Commons Attribution Non-Commercial 2.5 license. This license allows authors to re-use their articles for educational and research purposes as long as the author and the journal are fully acknowledged.

                History
                : 5 May 2008
                : 8 September 2009
                Page count
                Figures: 1, Tables: 2, References: 27, Pages: 5
                Categories
                Original Paper

                sheep fetus,hippocampus,cerebellum,faslodex,fulvestrant
                sheep fetus, hippocampus, cerebellum, faslodex, fulvestrant

                Comments

                Comment on this article